Unveiling Patient Experiences in Testicular Cancer Clinical Trials
Launched by POWER LIFE SCIENCES INC. · Jun 23, 2023
Trial Information
Current as of November 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand the experiences of men with testicular cancer who participate in medical research. The goal is to gather information about why some individuals choose to join these studies and what challenges they face. By collecting this data, researchers hope to improve the way clinical trials are conducted, making them more accessible and beneficial for patients in the future.
To be eligible for this trial, you must be at least 18 years old, have a diagnosis of testicular cancer, and have not received any previous treatment for it. Participants will need to provide written consent to join the study. This trial is not yet recruiting, but once it starts, those who take part can expect to share their experiences and thoughts, which will help shape future research efforts. It's important to note that individuals with certain mental health or substance abuse issues, those already enrolled in another study, or those unable to give consent will not be eligible to participate.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- • Diagnosis of testicular cancer
- • No prior treatment for testicular cancer
- Exclusion Criteria:
- • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
- • Enrolled in another research study
- • Inability to provide written informed consent
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported